236 related articles for article (PubMed ID: 29369969)
1. The Long Journey of mTOR Inhibitors and the Long Path That Is Still Ahead.
Tedesco Silva H
Transplantation; 2018 Feb; 102(2S Suppl 1):S1-S2. PubMed ID: 29369969
[No Abstract] [Full Text] [Related]
2. mTOR Inhibition and Clinical Transplantation: Kidney.
Flechner SM
Transplantation; 2018 Feb; 102(2S Suppl 1):S17-S18. PubMed ID: 28230636
[No Abstract] [Full Text] [Related]
3. mTOR Inhibition and Clinical Transplantation: Heart.
Zuckermann A; Osorio-Jaramillo E; Aliabadi-Zuckermann AZ
Transplantation; 2018 Feb; 102(2S Suppl 1):S27-S29. PubMed ID: 29369971
[TBL] [Abstract][Full Text] [Related]
4. mTOR Inhibition and Clinical Transplantation: Pancreas and Islet.
Berney T; Andres A; Toso C; Majno P; Squifflet JP
Transplantation; 2018 Feb; 102(2S Suppl 1):S30-S31. PubMed ID: 28230643
[TBL] [Abstract][Full Text] [Related]
5. mTOR Inhibition and Kidney Diseases.
Ma MKM; Yung S; Chan TM
Transplantation; 2018 Feb; 102(2S Suppl 1):S32-S40. PubMed ID: 29369972
[TBL] [Abstract][Full Text] [Related]
6. Transplantation: time to rethink immunosuppression by mTOR inhibitors?
Säemann MD; Remuzzi G
Nat Rev Nephrol; 2009 Nov; 5(11):611-2. PubMed ID: 19855420
[TBL] [Abstract][Full Text] [Related]
7. Impact of mTOR-I on fertility and pregnancy: state of the art and review of the literature.
Framarino-dei-Malatesta M; Derme M; Manzia TM; Iaria G; De Luca L; Fazzolari L; Napoli A; Berloco P; Patel T; Orlando G; Tisone G
Expert Rev Clin Immunol; 2013 Aug; 9(8):781-9. PubMed ID: 23971756
[TBL] [Abstract][Full Text] [Related]
8. mTOR Inhibition and Cardiovascular Diseases: Cardiac Hypertrophy.
Paoletti E
Transplantation; 2018 Feb; 102(2S Suppl 1):S41-S43. PubMed ID: 28230637
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus, the first mTOR inhibitor.
Sánchez-Plumed JA; González Molina M; Alonso A; Arias M
Nefrologia; 2006; 26 Suppl 2():21-32. PubMed ID: 17937632
[No Abstract] [Full Text] [Related]
10. Prophylactic use of mTOR inhibitors and other immunosuppressive agents in heart transplant patients.
Santoni M; Massari F; Cascinu S
Cell Mol Immunol; 2015 Jan; 12(1):122-4. PubMed ID: 24882385
[No Abstract] [Full Text] [Related]
11. mTOR Inhibition and Clinical Transplantation: Liver.
Nashan B
Transplantation; 2018 Feb; 102(2S Suppl 1):S19-S26. PubMed ID: 28230639
[TBL] [Abstract][Full Text] [Related]
12. Safety of mTOR inhibitors in adult solid organ transplantation.
Ventura-Aguiar P; Campistol JM; Diekmann F
Expert Opin Drug Saf; 2016; 15(3):303-19. PubMed ID: 26667069
[TBL] [Abstract][Full Text] [Related]
13. mTOR inhibitors in pancreas transplant: adverse effects and drug-drug interactions.
Fernandes-Silva G; Ivani de Paula M; Rangel ÉB
Expert Opin Drug Metab Toxicol; 2017 Apr; 13(4):367-385. PubMed ID: 27659512
[TBL] [Abstract][Full Text] [Related]
14. Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs.
Lindenfeld J; Miller GG; Shakar SF; Zolty R; Lowes BD; Wolfel EE; Mestroni L; Page RL; Kobashigawa J
Circulation; 2004 Dec; 110(25):3858-65. PubMed ID: 15611389
[No Abstract] [Full Text] [Related]
15. Treatment with mTOR inhibitors after liver transplantation enables a sustained increase in regulatory T-cells while preserving their suppressive capacity.
Ghazal K; Stenard F; Dahlqvist G; Barjon C; Aoudjehane L; Scatton O; Conti F
Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):237-244. PubMed ID: 29175009
[TBL] [Abstract][Full Text] [Related]
16. The Role of mTOR Inhibitors in the Management of Viral Infections: A Review of Current Literature.
Bowman LJ; Brueckner AJ; Doligalski CT
Transplantation; 2018 Feb; 102(2S Suppl 1):S50-S59. PubMed ID: 29369973
[TBL] [Abstract][Full Text] [Related]
17. [Everolimus and azoospermia, a causal relationship? About one case in a renal transplant patient].
Wetzstein M; Weestel PF; Choukroun G
Nephrol Ther; 2014 Feb; 10(1):44-5. PubMed ID: 24374233
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive minimization with mTOR inhibitors and belatacept.
Diekmann F
Transpl Int; 2015 Aug; 28(8):921-7. PubMed ID: 25959589
[TBL] [Abstract][Full Text] [Related]
19. Everolimus: a guide to its use in liver transplantation.
Keating GM; Lyseng-Williamson KA
BioDrugs; 2013 Aug; 27(4):407-11. PubMed ID: 23696253
[TBL] [Abstract][Full Text] [Related]
20. Mammalian target of rapamycin inhibition after solid organ transplantation: can it, and does it, reduce cancer risk?
Bhat M; Watt KD
Clin Transplant; 2015 Jul; 29(7):654-63. PubMed ID: 26094583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]